Primary data · sourced from public filings·700+ listed companies · India-first·Claude API · Healthy · —msOpen screener

Aletheia · Disclosure Card

Cholamandalam Investment

CHOLAFIN · NBFC

MARKET CAP

1.1L Cr

PE

32.4x

PB

5.8x

ROE

18.4%

REV GROWTH

28.4%

DISCLOSURE HEALTH SCORE

82/100
HIGH QUALITY

Strong across all disclosure dimensions. Holds up to scrutiny.

01WEAK
14.8%WEAK8/20

ROCE of 14.8% is marginal. Business may be destroying economic value depending on cost of capital.

02ADEQUATE
1.12ADEQUATE14/20

OCF/PAT ratio of 1.12 — broadly in line with profit. Minor non-cash items at play.

03CLEAN
0% pledgedCLEAN20/20

No promoter pledge. Promoter holding is unencumbered — full alignment with minority shareholders.

04N/A
D/E 6.2xN/A20/20

D/E ratio is not meaningful for financial sector companies — they are inherently leveraged.

05N/A
FCF ≤ 0N/A20/20

FCF Yield is not a standard metric for financial companies — use ROE and credit cost instead.

← BACK TO SCREENERSECTOR PE →GET FULL AUDIT →

Data is representative and for educational purposes only. Not investment advice. Verify all data on Screener.in, BSE, or NSE before any investment decision.

AletheiaAI — The truth layer for India's public markets. 700+ companies, scored.